Yaz Panel Was Filled With ‘Irregularities’: Advocates
1 CommentBy Ed Silverman // March 16th, 2012 // 10:13 am
• Pharma Blog » Archives
Bayer
The Op-Ed: Can FDA Review All Those DTC Ads?
Make a commentBy Ed Silverman // March 13th, 2012 // 8:09 am
Game Changer: India Issues 1st Compulsory License
2 CommentsBy Ed Silverman // March 12th, 2012 // 7:26 am
Will FDA Delay Approving The Eliquis Bloodthinner?
Make a commentBy Ed Silverman // February 29th, 2012 // 8:28 am
Pharmalot… Pharmalittle… Good Morning
Make a commentBy Ed Silverman // February 28th, 2012 // 7:59 am
Up And Down The Ladder… Job Changes
Make a commentBy Ed Silverman // February 17th, 2012 // 8:28 am
Pharmalot… Pharmalittle… The Weekend Nears
3 CommentsBy Ed Silverman // February 17th, 2012 // 8:04 am